Cargando…

Intranasal Dopamine Reduces In Vivo [(123)I]FP-CIT Binding to Striatal Dopamine Transporter: Correlation with Behavioral Changes and Evidence for Pavlovian Conditioned Dopamine Response

Purpose: Dopamine (DA), which does not cross the blood-brain barrier, has central and behavioral effects when administered via the nasal route. Neither the mechanisms of central action of intranasal dopamine (IN-DA), nor its mechanisms of diffusion and transport into the brain are well understood. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Souza Silva, Maria A., Mattern, Claudia, Decheva, Cvetana, Huston, Joseph P., Sadile, Adolfo G., Beu, Markus, Müller, H.-W., Nikolaus, Susanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840254/ https://www.ncbi.nlm.nih.gov/pubmed/27148001 http://dx.doi.org/10.3389/fnbeh.2016.00080

Ejemplares similares

Case Report: Bupropion Reduces the [(123)I]FP-CIT Binding to Striatal Dopamine Transporter
por: Milenkovic, Ivan, et al.
Publicado: (2021)

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT
por: Mäkinen, Elina, et al.
Publicado: (2019)

Effects of l-DOPA on striatal iodine-123-FP-CIT binding and behavioral parameters in the rat
por: Nikolaus, Susanne, et al.
Publicado: (2013)

Lower (123)I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies
por: Joling, Merijn, et al.
Publicado: (2018)

Serotonergic Modulation of Nigrostriatal and Mesolimbic Dopamine and Motor/Exploratory Behaviors in the Rat
por: Nikolaus, Susanne, et al.
Publicado: (2021)

No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
por: Thomsen, Gerda, et al.
Publicado: (2013)

Imaging of dopamine transporters in Parkinson disease: a meta‐analysis of (18)F/(123)I‐FP‐CIT studies
por: Kong, Yanyan, et al.
Publicado: (2020)

Dopamine transporter imaging with [(18)F]FE-PE2I PET and [(123)I]FP-CIT SPECT—a clinical comparison
por: Jakobson Mo, Susanna, et al.
Publicado: (2018)

Relationship Between L-DOPA-Induced Reduction in Motor and Exploratory Activity and Striatal Dopamine D(2) Receptor Binding in the Rat
por: Nikolaus, Susanne, et al.
Publicado: (2016)

Corrigendum: Relationship Between L-DOPA-Induced Reduction in Motor and Exploratory Activity and Striatal Dopamine D(2) Receptor Binding in the Rat
por: Nikolaus, Susanne, et al.
Publicado: (2016)

A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [(123)I]I-FP-CIT SPECT in routine practice
por: Chahid, Youssef, et al.
Publicado: (2023)

[(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2022)

The utility of the combination of a SPECT study with [(123)I]-FP-CIT of dopamine transporters and [(123)I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
por: Uyama, Naoto, et al.
Publicado: (2017)

Combination of In Vivo [(123)I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum
por: Park, So Hyeon, et al.
Publicado: (2019)

Correction: [(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2023)

Plasticity in striatal dopamine release is governed by release-independent depression and the dopamine transporter
por: Condon, Mark D., et al.
Publicado: (2019)

Altered dopaminergic pathways and therapeutic effects of intranasal dopamine in two distinct mouse models of autism
por: Chao, Owen Y., et al.
Publicado: (2020)

Imaging of serotonin transporters with [(123)I]FP-CIT SPECT in the human hypothalamus
por: Borgers, Anke J, et al.
Publicado: (2013)

Dysfunctions in Dopamine Systems and ADHD: Evidence From Animals and Modeling
por: Viggiano, Davide, et al.
Publicado: (2004)

Responsivity of the Striatal Dopamine System to Methylphenidate—A Within-Subject I-123-β-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
por: Aster, Hans-Christoph, et al.
Publicado: (2022)

Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal (123)I-FP-CIT indices
por: Nicastro, Nicolas, et al.
Publicado: (2019)

Dopamine regulation of striatal inhibitory transmission and plasticity: dopamine, low or high?
por: Hernández-Echeagaray, Elizabeth
Publicado: (2016)

Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging
por: Heng, Nicholas, et al.
Publicado: (2023)

Reduced Striatal Dopamine Transporters in People with Internet Addiction Disorder
por: Hou, Haifeng, et al.
Publicado: (2012)

Changes in striatal dopamine transporters in bipolar disorder and valproate treatment
por: Hsueh, Yuan-Shuo, et al.
Publicado: (2021)

Local control of striatal dopamine release
por: Cachope, Roger, et al.
Publicado: (2014)

Abnormal Striatal Dopamine Transmission in Schizophrenia
por: Brunelin, Jerome, et al.
Publicado: (2013)

Striatal Dopamine Signals and Reward Learning
por: Bech, Pol, et al.
Publicado: (2023)

Clinicopathological and (123)I‐FP‐CIT SPECT correlations in patients with dementia
por: Jung, Youngsin, et al.
Publicado: (2018)

GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
por: Nikolaus, Susanne, et al.
Publicado: (2018)

Sex Differences in Behavioral Responding and Dopamine Release during Pavlovian Learning
por: Lefner, Merridee J., et al.
Publicado: (2022)

Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease
por: Passamonti, Luca, et al.
Publicado: (2013)

Correlation of Plasma EGF with Striatal Dopamine Transporter Availability in Healthy Subjects
por: Pak, Kyoungjune, et al.
Publicado: (2017)

Processing speed is related to striatal dopamine transporter availability in Parkinson's disease
por: Vriend, Chris, et al.
Publicado: (2020)

Focal (123)I-FP-CIT SPECT Abnormality in Midbrain Vascular Parkinsonism
por: Solla, Paolo, et al.
Publicado: (2015)

Autopsy validation of (123)I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB
por: Thomas, Alan J., et al.
Publicado: (2017)

Japanese multicenter database of healthy controls for [(123)I]FP-CIT SPECT
por: Matsuda, Hiroshi, et al.
Publicado: (2018)

The dopamine transporter antiports potassium to increase the uptake of dopamine
por: Schmidt, Solveig G., et al.
Publicado: (2022)

Striatal Dopamine and the Interface between Motivation and Cognition
por: Aarts, Esther, et al.
Publicado: (2011)

Endocannabinoid–Dopamine Interactions in Striatal Synaptic Plasticity
por: Mathur, Brian N., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cgh65qfcb8u9cnhqegtbp0rcas